NCT06251154

Brief Summary

This study was designed to gather short-term clinical performance data for 2 soft contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 11, 2023

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2024

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
2 months until next milestone

Results Posted

Study results publicly available

April 16, 2024

Completed
Last Updated

August 22, 2024

Status Verified

January 1, 2024

Enrollment Period

28 days

First QC Date

January 30, 2024

Results QC Date

March 18, 2024

Last Update Submit

August 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Subjective Overall Score

    Subjective overall score was assessed using 0-100 visual analogue scale, where 0=Extremely poor, unmanageable, cannot use lenses and 100=Excellent, highly impressed with these lenses overall

    15 minutes

Secondary Outcomes (2)

  • Subjective Comfort

    15 minutes

  • Subjective Vision

    15 minutes

Study Arms (2)

Lens 1

EXPERIMENTAL

All participants wore Lens 1 for 15 minutes (Period 1)

Device: Lens 1

Lens 2

EXPERIMENTAL

All participants wore Lens 2 for 15 minutes (Period 2)

Device: Lens 2

Interventions

Lens 1DEVICE

Daily disposable silicone hydrogel contact lens (diameter=14.0mm) for 15 minutes

Lens 1
Lens 2DEVICE

Daily disposable silicone hydrogel contact lens (diameter=14.1mm) for 15 minutes

Lens 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects will only be eligible for the study if:
  • They were of legal age (18) and capacity to volunteer.
  • They understood their rights as a research subject and were willing and able to sign a Statement of Informed Consent.
  • They were willing and able to follow the protocol.
  • They were wearing soft contact lenses, or had done so within the past two years.
  • They were able to be fitted with the study lenses within the power range available.

You may not qualify if:

  • Subjects will not be eligible if:
  • They had an ocular disorder which would normally contra-indicate contact lens wear.
  • They had a systemic disorder which would normally contra-indicate contact lens wear.
  • They were using any topical medication such as eye drops or ointment.
  • They were aphakic.
  • They had had corneal refractive surgery.
  • They had any corneal distortion resulting from previous hard or rigid lens wear or had keratoconus.
  • They were pregnant or lactating.
  • They had an eye or health condition including an immunosuppressive or infectious disease which could, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction.
  • They had taken part in any contact lens or care system clinical research within two weeks prior to starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eurolens Research

Manchester, M13 9PL, United Kingdom

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
José A. Vega OD, MSc, PhD, FAAO
Organization
CooperVision, Inc.

Study Officials

  • Carole Maldonado-Codina, PhD MCOptom

    Eurolens Research

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 9, 2024

Study Start

December 11, 2023

Primary Completion

January 8, 2024

Study Completion

January 8, 2024

Last Updated

August 22, 2024

Results First Posted

April 16, 2024

Record last verified: 2024-01

Locations